Belvedere Trading’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Belvedere Trading’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,029	Closed	-$29.4K	–	1643
2022 Q4	$29.4K	Buy	+5,029	New	+$26.4K	﹤0.01%	763

Belvedere Trading's CNCE Position: Q1 2023 in Review

Belvedere Trading sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 5,029 shares — an estimated $29.4K sold.

Belvedere Trading first reported a position in CNCE in Q4 2022 and held it in 1 quarter. The position peaked at $29.4K in Q4 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

Belvedere Trading reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Belvedere Trading sold 5,029 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $29.4K.
Belvedere Trading first reported a position in Concert Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Belvedere Trading's Concert Pharmaceuticals, Inc. position peaked at $29.4K in Q4 2022.
0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.